Sunshine Biopharma settles mutual release with former CEO Chamoun
Sunshine Biopharma and subsidiary Nora Pharma have settled all claims with former CEO Malek Chamoun following a mutual release agreement. The full settlement resolves complex legal issues surrounding the executive's termination, potentially reducing future financial and reputatio
View filing at SEC.gov →